In addition to studies submitted to the FDA, 170 other independent studies since 2007—including 53 critical care studies—have found no clinically significant interferences for StatStrip's measurement technology. This is a statement that no other glucose meter manufacturer can make. StatStrip and StatStrip Xpress2 are the world’s most extensively studied and proven glucose test. It has been proven to be safe and effective for use throughout all hospital and professional healthcare settings including critical care.
The StatStrip Glucose/Ketone Hospital Meter System offers bidirectional wireless connectivity to hospital HIS or LIS with complete security to protect patient data.
Easy to use
No meter preparation or calibration coding steps are required. Insert a ketone strip and StatStrip Glucose/Ketone meter automatically recognizes the strip and converts the meter to ketone measuring mode.
Blood ketone testing should be performed whenever glucose exceeds 14 mmol/L (250 mg/dL)
Diabetes UK, the Canadian Diabetes Association, the European Society for Paediatric Endocrinology, and the American Diabetes Association (ADA) recommend that blood ketone testing be performed whenever glucose exceeds 14 to 17 mmol/L for rapid detection or prevention of diabetic ketoacidosis (DKA).
StatStrip Glucose/Ketone measures blood beta-hydroxybutyrate, the preferred ketone for diagnosing ketoacidosis
According to the European Society for Paediatric Endocrinology, Diabetes UK, ADA, and others, blood ketone testing methods that quantify beta-hydroxybutyrate, the predominant ketone body in DKA, are recommended over urine ketone testing for diagnosing and monitoring ketoacidosis.
Ketone testing results obtained from capillary samples
Capillary blood samples are not only preferred over urine samples to detect and monitor DKA,
they are also easier to obtain and allow for immediate reflex testing of ketones whenever glucose is greater than 14 mmol/L.
Blood ketone monitoring reduces costs and ICU length of stay for DKA patients
An ICU study evaluated the effectiveness of blood ketone testing versus urine ketone testing for DKA patients. The blood ketone testing group of patients left the ICU 6.5 hours earlier than the urine ketone testing group. This led to savings of 22 hours of nursing time and 375 laboratory investigations, for a total savings of €2,940.1
A second study of DKA patients compared a DKA therapy endpoint of pH > 7.3 and blood ketones < 1.0 mmol/L, versus an endpoint of pH > 7.3 and negative urine ketones. The pH/ blood ketone endpoint was reached after 17 hours, whereas the pH/urine ketone endpoint was not reached until 28 hours after starting treatment. The mean lag between the blood ketone and urine ketone groups was 11 hours, ranging from 1 to 36 hours.2
Blood ketone is more accurate than urine ketone testing
Blood beta-hydroxyburyrate testing indicates the patient’s status at the time of the test, whereas urine may have been in the bladder for several hours. Urine testing can also produce false positive or negative results due to highly colored urine, highly acidic urine, exposure of the urine test strips to air for prolonged periods, drugs such as the ACE inhibitor captopril, or high doses
of vitamin C.
*Ketone testing is not available with StatStrip meters in the U.S. Glucose is available.
In order to help hospitals avoid the risk of glucose meter off-label use, Nova Biomedical’s technical support resources are ready to help you acquire the StatStrip Glucose Hospital Meter System. To learn more about how StatStrip Glucose can bring critical care testing to the bedside, contact your current GPO or call Nova at 800-458-5813.
1. Vanelli et al. (2003). Cost effectiveness of the direct measurement of 3-β-hydroxybutyrate in the management of diabetic ketoacidosis in children [Letter to the editor]. Diabetes Care, 26(3), 959.
2. Noyes et al. (2007). Hydroxybutyrate near-patient testing to evaluate a new end-point for intravenous insulin therapy in the treatment of diabetic ketoacidosis in children. Pediatric Diabetes, 8, 150-156.
Not available in the U.S.
Weight: 220 g (0.49 lb)
Size: 147 mm x 79 mm x 30 mm
(5.8 in x 3.1 in x 1.18 in)
Glucose and Ketone Testing in One Meter
(ADA recommends ketone testing when glucose >250 mg/dL or >14 mmol/L)
Data Storage:
Patient Tests: 1,000 tests
QC Tests: 200 tests
Users: 8,000 users
Connectivity:
Meter Data Output: RJ-45 Ethernet Port
Protocol: TCP/IP Ethernet 100 Mbit Standard: POCT1-A2
Compliant
Setup Program: NovaNet™ Web-Based Instrument Manager Software
Battery Information:
Type: 3.7V Li Polymer Rechargeable Battery
Features: Rechargeable/Replaceable
Life: 6-8 hours in use (approximately 40 tests w/barcode scans)/12-24 hours standby
Docking Station:
Optional accessory; desk or wall mount charging station with RJ-45 Ethernet jack. 3 LED indicator lights showing connection status, transmit/receive data, and charging status. Extra battery slot included for recharging and storage of spare battery.
Additional Features:
Not available in the U.S. and Canada
Designed for applications that do not need data interfacing and connectivity, Xpress2 retains all of the analytical performance features of StatStrip Glucose.
Weight: 78 g (2.77 oz)
Data Storage:
Patient & QC Tests: 400 tests total (FIFO)
Connectivity:
Data Transfer: Strip Port Connection to USB
Data Program: Nova Microsoft-Excel based data transfer software
Battery Information:
Type: Type: 2x 1.5V AAA Battery
Features: Replaceable
Life: Minimum 600 tests
Additional Features:
Certifications and Compliance: Nova Biomedical is certified to FDA Quality System Regulations and EN ISO 13485:2016
Complies to IVDD Tested according to: EN 61010-1:2010, EN 61010-2-101:2015, EN 60825-1/A1:2014. UL, CSA Standards Patented Technology. Patents 6,287,451 / 6,837,976 / EP 1 212 609 / CA 2,375,092 / EP 1497 449 / JP 405 0078
Specifications subject to change without notice
Tests:
Test Measured: Ketone*, Hematocrit corrected
Test Reported: Ketone
Test Time: 10 Seconds
Test Strip Volume: 0.8 μL
Ketone Measurement Range: 0.0-8.0 mmol/L
*ß-hydroxybutyrate
Sample Types & Operating Modes:
Whole Blood: Arterial, Venous, Capillary
Operating Ranges:
Temperature: 5°C- 40°C (41°F-104°F)
Altitude: 4,572 m (Up to 15,000 ft)
Humidity: 10% to 90% relative humidity
Hematocrit: 20%-65%
Reagents and Strips:
Strips: 1 Box of 50 strips (25 strips per vial, 2 vials per box)
QC: Three levels (Low, Normal, High)
Linearity: Five levels available
Certifications and Compliance: Nova Biomedical is certified to FDA Quality System Regulations and EN ISO 13485:2016
Complies to IVDD Tested according to: EN 61010-1:2010, EN 61010-2-101:2015, EN 60825-1/A1:2014. UL, CSA Standards Patented Technology.
Patents 6,287,451 / 6,837,976 / EP 1 212 609 / CA 2,375,092 / EP 1497 449 / JP 405 0078 Specifications subject to change without notice.
Tests:
Tests Measured: Glucose and Hematocrit
Test Reported: Glucose
Test Time: 6 Seconds
Test Strip Volume: 1.2 µL
Test Methodology: Electrochemistry
Sample Types & Operating Modes:
Whole Blood: Arterial, Venous, Capillary, Neonatal
Glucose Measurement Range:
0.6-33.3 mmol/L (10-600 mg/dL)
Interferences Eliminated Include:
Hematocrit, Ascorbic Acid, Uric Acid, Paracetamol (Acetaminophen), Bilirubin, Maltose, Galactose, Oxygen
Operating Ranges:
Temperature: 15°C- 40°C (59°F-104°F)
Altitude: 4,572 m (Up to 15,000 ft)
Humidity: 10% to 90% relative humidity
Reagents and Strips:
Strips: Cases of 36 vials (1,800 strips); vials packaged 50 strips/vial
QC: Three levels (Low, Normal, High); sold separately
Linearity: Five levels available
Test Strip Stability:
30 months from date of manufacturing outside USA
180-day open-vial stability
QC Stability:
24 months from date of manufacturing
90-day open-vial stability
Certifications and Compliance: Nova Biomedical is certified to FDA Quality System Regulations and EN ISO 13485:2016 Complies to IVDD Tested according to: EN 61010-1:2010, EN 61010-2-101:2015, EN 60825-1/A1:2014.
CSA Standards. Patented Technology. Patents 6,287,451 / 6,837,976 / EP 1 212 609 / CA 2,375,092 / EP 1497 449 / JP 405 0078
Specifications current as of revision date.